Impact of Tofacitinib on Fracture Risk in Rheumatoid Arthritis

被引：0

作者：

Hansen, Karen E. ^{[1
]}

Mortezavi, Mahta ^{[2
]}

Nagy, Edward ^{[3
]}

Wang, Cunshan ^{[4
]}

Connell, Carol A. ^{[4
]}

Radi, Zaher ^{[5
]}

Litman, Heather J. ^{[6
]}

Adami, Giovanni ^{[7
]}

Rossini, Maurizio ^{[7
]}

机构：

[1] Univ Wisconsin, Rheumatol Div, Dept Med, Sch Med & Publ Hlth, Madison, WI USA

[2] Pfizer Inc, New York, NY USA

[3] Pfizer Ltd, Tadworth, England

[4] Pfizer Inc, Groton, CT USA

[5] Pfizer Inc, Cambridge, MA USA

[6] CorEvitas LLC, Waltham, MA USA

[7] Univ Verona, Dept Med, Rheumatol Unit, Verona, Italy

来源：

ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1431

引用

页码：2821 / 2824

页数：4

共 50 条

[21] Hematological Impact Assessment of Tofacitinib, Baricitinib, and Upadacitinib in Rheumatoid Arthritis Treatment
Ahn, Soo Min
Cho, Mi-Ra
Oh, Ji Seon
Kim, Yong-Gil
Lee, Chang-Keun
Yoo, Bin
Hong, Seokchan
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1061 - 1064
[22] CARDIOVASCULAR AND ADVERSE EVENTS RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS IN THE DOMINICAN REPUBLIC
Alvarez Santana, R. A.
Garcia, D.
Perez, L.
Polanco Mora, T.
Concepcion Sanchez, L.
Paulino, I.
Mercedes, I.
Rodriguez Bautista, E.
Valdez, T.
Feriz, A.
Munoz Louis, R.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1446 - 1447
[23] IMPACT OF CARDIOVASCULAR COMORBIDITIES ON EFFICACY OF TOFACITINIB VS TNFI IN RHEUMATOID ARTHRITIS
Buch, M. H.
Mortezavi, M.
Giles, J.
Charles-Schoeman, C.
Karpouzas, G.
Jo, H.
Kwok, K.
Nagy, E.
Rivas, J. L.
Yndestad, A.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 27 - 28
[24] BUDGET IMPACT ANALYSIS OF TOFACITINIB IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN IRAQ
AlAni, N.
Sunna, N.
Ghorab, A.
AlJabban, A.
Awad, N.
Mohamed, O.
VALUE IN HEALTH, 2019, 22 : S167 - S167
[25] Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
Kunihiro Yamaoka
Drug Safety, 2016, 39 : 823 - 840
[26] Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
Yamaoka, Kunihiro
DRUG SAFETY, 2016, 39 (09) : 823 - 840
[27] Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Lee, Eun Bong
Fleischmann, Roy
Hall, Stephen
Wilkinson, Bethanie
Bradley, John D.
Gruben, David
Koncz, Tamas
Krishnaswami, Sriram
Wallenstein, Gene V.
Zang, Chuanbo
Zwillich, Samuel H.
van Vollenhoven, Ronald F.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25): : 2377 - 2386
[28] Persistence on tofacitinib therapy in rheumatoid arthritis
Fisher, Anat
Dormuth, Colin
Hudson, Marie
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 471 - 471
[29] Tofacitinib against methotrexate in rheumatoid arthritis
Sanz Rubio, M.
REVISTA CLINICA ESPANOLA, 2014, 214 (09): : 535 - 536
[30] Tofacitinib for the treatment of rheumatoid arthritis: an update
Yamaoka, Kunihiro
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (06) : 577 - 588

← 1 2 3 4 5 →